Verastem Inc stock is traded at $9.85, with a volume of 2,511,973. It is up +0.82% in the last 24 hours and up +27.92% over the past month. Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Previous Close:
$9.77
Open:
$10.00
24h Volume:
2,511,973
Relative Volume:
0.76
Market Cap:
$1.20B
Revenue:
$30.91M
Net Income/Loss:
-$209.47M
P/E Ratio:
-
EPS:
-$3.33
Net Cash Flow:
-$147.13M
1W Performance:
+0.15%
1M Performance:
+27.92%
6M Performance:
+65.55%
1Y Performance:
+24.53%
1-Day Range:
$9.42$10.10
1-Week Range:
$9.42$10.10
52-Week Range:
$3.43$10.82
Verastem Inc Stock (VSTM) Company Profile
Name
Verastem IncSector
HealthcareIndustry
BiotechnologyPhone
(781) 292-4200Address
117 KENDRICK STREET, NEEDHAM, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS